Nicholas Butowski

University of California, San Francisco — United States

Medicine · Health Sciences

68h-index18.3kcitations599works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(432), Cancer, Hypoxia, and Metabolism(153), ATP Synthase and ATPases Research(93), Radiomics and Machine Learning in Medical Imaging(74), Brain Metastases and Treatment(64)

Publications592 total

A genomically-tailored multi-agent precision medicine clinical trial for adults with recurrent glioblastoma
Clinical Cancer Research·2026Open Access
STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma
Journal of Clinical Oncology·2025Open Access
A Clinical Tool to Identify Incidental Meningioma for Early Outpatient Management
JAMA Oncology·2025Open Access
A framework for using DNA methylation-based modelling for the clinical management of cranial meningioma
Neuro-Oncology·2025Open Access
RADT-50. SAFETY AND FEASIBILITY OF YTTRIUM-90 GLASS MICROSPHERE RADIATION THERAPY IN RECURRENT GLIOBLASTOMA: RESULTS FROM THE FIRST 12 PATIENTS TREATED IN THE FRONTIER TRIAL
Neuro-Oncology·2025Open Access
INNV-06. Build it and they will come: Cognitive rehabilitation in primary brain tumor
Neuro-Oncology·2025Open Access
PATH-89. The single cell landscape of NF1-associated gliomas pre- and post-treatment and comparison to their sporadic counterparts
Neuro-Oncology·2025Open Access
DDEL-22. Safety, feasibility, and preliminary efficacy of albumin-bound paclitaxel as monotherapy and in combination with carboplatin delivered by blood-brain barrier opening using a skull-implantable ultrasound: Preliminary results of a Phase I-II trial in recurrent glioblastoma
Neuro-Oncology·2025
TIP-02. Evaluation of TB006, a Galectin-3 antibody, for the treatment of Glioblastoma
Neuro-Oncology·2025Open Access
TIP-08. Trial in progress update: A phase 1/2 study of intracranial and intravenous multi-dosing of DB107-RRV (formerly Toca 511) and DB107-FC (5-fluorocytosine) in combination with radiation ± temozolomide (TMZ) in patients with newly diagnosed high-grade gliomas (HGGs)
Neuro-Oncology·2025Open Access
QOL-02. Tele-Cognitive rehabilitation for adult lower grade glioma: A prospective feasibility study
Neuro-Oncology·2025Open Access
CTNI-58. UPDATED RESULTS OF PHASE 3 STELLAR TRIAL: EFLORNITHINE IMPROVES OVERALL SURVIVAL AND BLINDED INDEPENDENT CENTRAL REVIEW DETERMINED PROGRESSION FREE SURVIVAL IN PATIENTS WITH RECURRENT WHO 2021 GRADE 3 IDH-MUTANT ASTROCYTOMA
Neuro-Oncology·2025Open Access
P02.02.A IL6 UNDERLIES MICROENVIRONMENT IMMUNOSUPPRESSION AND RESISTANCE TO THERAPY IN GLIOBLASTOMA
Neuro-Oncology·2025Open Access
P17.35.B SAFETY AND FEASIBILITY OF YTTRIUM-90 GLASS MICROSPHERES IN RECURRENT GLIOBLASTOMA: RESULTS FROM THE FIRST 12 PATIENTS TREATED IN THE FRONTIER TRIAL
Neuro-Oncology·2025Open Access
P15.04.B TELE-COGNITIVE REHABILITATION FOR ADULT LOWER GRADE GLIOMA: A PROSPECTIVE FEASIBILITY STUDY
Neuro-Oncology·2025Open Access
Phase Ib/II Study of Pamiparib Plus Radiation Therapy and/or Temozolomide in Adult Patients with Treatment-Naïve or Recurrent/Refractory Glioblastoma
Current Oncology·2025Open Access
Longitudinal voxel-wise analysis using a novel deep-learning-derived KI-67 map for early prediction of glioblastoma outcome
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition·2025
Novel radiotherapy target definition using AI-driven predictions of glioblastoma recurrence from metabolic and diffusion MRI
npj Digital Medicine·2025· 1 citedOpen Access
Tele-cognitive rehabilitation for adult lower-grade glioma: An interim prospective pilot feasibility study
Neuro-Oncology Practice·2025Open Access
O-047 Technical considerations in superselective intra-arterial cerebral delivery of yttrium-90 microspheres to recurrent glioblastoma
2025
page 1 of 30Next →

Frequent Co-authors

Patrick Y. Wen(20), Mitchel S. Berger(16), Michael D. Prados(15), Arie Perry(14), Jennifer Clarke(12), Ho‐Keung Ng(12), Joanna J. Phillips(11), Susan M. Chang(11), Farshad Nassiri(10), Andrew E. Sloan(9), Larry Junck(9), Burt Nabors(9), David R. Raleigh(9), Kenneth Aldape(9), Tobias Walbert(9), Maciej M. Mrugała(8), Jana Portnow(8), Annette M. Molinaro(8), Manish K. Aghi(8), Craig Horbinski(8)